These data, along with the inverse relationship between serum CXCL10 levels and the percentage of CXCR3-positive T lymphocytes in the blood of BD patients, suggests a role for the CXCL10/CXCR3 axis in the trafficking of cells to the site of inflammation. This evidence concerns the gene CXCL10 and Behcet disease.